Decreased interleukin 4 serum levels correlate with plasminogen activator inhibitor-1 inhibitor TM5614 efficacy in patients with malignant melanoma refractory to anti-programmed cell death protein-1 antibodies: post hoc study of the TM5614-MM trial.
作者信息
Yamazaki Emi, Fujimura Taku, Takahashi-Watanabe Manami, Tada Satsuki, Kitayama Chisako, Amagai Ryo, Kambayashi Yumi, Watanabe Masahiro, Maekawa Masamitsu, Mano Nariyasu, Asano Yoshihide
机构信息
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
出版信息
Br J Dermatol. 2024 Dec 23;192(1):167-169. doi: 10.1093/bjd/ljae343.
PMID:39215562
Abstract
摘要
Zotero 插件